Open AccessPharmacoinvasive strategy in the treatment of acute myocardial infarction: current state-of-the-art
Author(s) -
А. С. Терещенко,
Т. М. Ускач,
Н. В. Кондратова
Publication year - 2021
Publication title -
rossijskij kardiologičeskij žurnal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.141
H-Index - 14
eISSN - 2618-7620
pISSN - 1560-4071
DOI - 10.15829/1560-4071-2021-4452
Subject(s) - medicine , myocardial infarction , percutaneous coronary intervention , cardiology , percutaneous , intervention (counseling) , fibrinolytic therapy , intensive care medicine , psychiatry
The existing clinical guidelines identify two main approaches to the treatment of patients with ST-segment elevation myocardial infarction: a primary percutaneous coronary intervention and a pharmacoinvasive strategy. Due to the time delays due to various reasons, it is not always easy to perform primary percutaneous coronary intervention timely (<120 minutes). Modern thrombolytic drugs make it easy and safe to apply a pharmacoinvasive strategy to a wide group of patients, improving their prognosis.